Abstract
Background: Since the landmark randomized trial of thymectomy in myasthenia gravis (MGTX), total thymectomy is considered standard of care in conjunction with medical management for myasthenia gravis (MG). We aim to report the incidence of thymomatous MG in our population, tumor histopathological characteristics, and background thymus tissue histopathological characteristics in comparison to those without MG. We also compared MG remission rate for thymomatous versus non-thymomatous MG. We hypothesize that the background thymus tissue in thymomatous MG differs than non-thymomatous MG with respect to volume of germinal centers, and that histology of thymoma in those with MG differs from those without MG.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
